Jantoven



Indications and Reactions:

Role Indications Reactions
Primary
Atrial Fibrillation 29.5%
Product Used For Unknown Indication 14.3%
Thrombosis Prophylaxis 8.0%
Pulmonary Embolism 6.3%
Anticoagulant Therapy 5.4%
Deep Vein Thrombosis 5.4%
Parkinson's Disease 3.6%
Transient Ischaemic Attack 3.6%
Cerebrovascular Accident 2.7%
Hypertension 2.7%
Renal Disorder 2.7%
Anxiety 1.8%
Cardiac Valve Prosthesis User 1.8%
Cerebrovascular Accident Prophylaxis 1.8%
Diabetes Mellitus 1.8%
Drug Use For Unknown Indication 1.8%
Factor V Leiden Mutation 1.8%
Heart Rate Increased 1.8%
Heart Valve Replacement 1.8%
Implantable Defibrillator Insertion 1.8%
International Normalised Ratio Increased 22.4%
International Normalised Ratio Decreased 16.3%
Prothrombin Time Prolonged 8.2%
Product Substitution Issue 6.1%
Prothrombin Time Abnormal 6.1%
Fall 4.1%
International Normalised Ratio Abnormal 4.1%
Medication Error 4.1%
Rash Pruritic 4.1%
Skin Necrosis 4.1%
Abdominal Pain Lower 2.0%
Age-related Macular Degeneration 2.0%
Anticoagulation Drug Level Below Therapeutic 2.0%
Anticonvulsant Drug Level Below Therapeutic 2.0%
Antiphospholipid Antibodies Positive 2.0%
Blood Pressure Increased 2.0%
Blue Toe Syndrome 2.0%
Chest Pain 2.0%
Confusional State 2.0%
Cystitis 2.0%
Secondary
Atrial Fibrillation 19.6%
Pulmonary Embolism 15.2%
Product Used For Unknown Indication 8.9%
Thrombosis Prophylaxis 8.9%
Anticoagulant Therapy 7.1%
Anxiety 3.6%
Blood Cholesterol Increased 3.6%
Coagulopathy 3.6%
Deep Vein Thrombosis 3.6%
Parkinson's Disease 3.6%
Blood Pressure 2.7%
Drug Use For Unknown Indication 2.7%
Gout 2.7%
Memory Impairment 2.7%
Thrombosis 2.7%
Cardiac Valve Prosthesis User 1.8%
Cerebrovascular Accident 1.8%
Cerebrovascular Accident Prophylaxis 1.8%
Diabetes Mellitus 1.8%
Extrasystoles 1.8%
International Normalised Ratio Decreased 22.4%
Transient Ischaemic Attack 14.3%
International Normalised Ratio Increased 12.2%
Petechiae 6.1%
Skin Necrosis 6.1%
Blue Toe Syndrome 4.1%
Prothrombin Time Prolonged 4.1%
Rash 4.1%
Wrong Drug Administered 4.1%
Blister 2.0%
Dementia 2.0%
Fall 2.0%
Hypotension 2.0%
International Normalised Ratio Fluctuation 2.0%
Local Swelling 2.0%
Malaise 2.0%
Nephrolithiasis 2.0%
Night Sweats 2.0%
Oedema Peripheral 2.0%
Pharmaceutical Product Complaint 2.0%
Concomitant
Product Used For Unknown Indication 33.7%
Drug Use For Unknown Indication 13.1%
Atrial Fibrillation 8.3%
Blood Pressure 5.5%
Hypertension 4.0%
Anticoagulant Therapy 3.2%
Blood Cholesterol Increased 3.2%
Multiple Myeloma 3.2%
Blood Cholesterol 2.8%
Rheumatoid Arthritis 2.5%
Systemic Lupus Erythematosus 2.5%
Thyroid Disorder 2.5%
Gastrooesophageal Reflux Disease 2.3%
Depression 2.1%
Diabetes Mellitus 2.1%
Cardiac Disorder 1.9%
Pain 1.9%
Arthritis 1.7%
Chronic Obstructive Pulmonary Disease 1.7%
Essential Hypertension 1.7%
Cardiac Arrest 7.1%
Unevaluable Event 7.1%
C-reactive Protein Increased 5.7%
Pneumonia 5.7%
Therapeutic Agent Toxicity 5.7%
Tremor 5.7%
Ventricular Tachycardia 5.7%
Weight Decreased 5.7%
Cardiac Failure Congestive 4.3%
Death 4.3%
Diarrhoea 4.3%
Flushing 4.3%
Hypertension 4.3%
Injury 4.3%
Myalgia 4.3%
Pulmonary Embolism 4.3%
Tachycardia 4.3%
Unresponsive To Stimuli 4.3%
Upper Gastrointestinal Haemorrhage 4.3%
Urinary Incontinence 4.3%
Interacting
Parkinson's Disease 32.0%
Thrombosis 24.0%
Anxiety 8.0%
Hypertension 8.0%
Thrombosis Prophylaxis 8.0%
Blood Cholesterol Increased 4.0%
Dry Eye 4.0%
Eye Disorder 4.0%
Rhinorrhoea 4.0%
Type 2 Diabetes Mellitus 4.0%
International Normalised Ratio Increased 37.5%
International Normalised Ratio Decreased 25.0%
Restlessness 25.0%
Urine Abnormality 12.5%